Hunan Jingfeng Pharmaceutical (000908) - Net Assets

Latest as of September 2025: CN¥-37.76 Million CNY ≈ $-5.52 Million USD

Based on the latest financial reports, Hunan Jingfeng Pharmaceutical (000908) has net assets worth CN¥-37.76 Million CNY (≈ $-5.52 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥877.99 Million ≈ $128.48 Million USD) and total liabilities (CN¥915.74 Million ≈ $134.00 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Hunan Jingfeng Pharmaceutical asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥-37.76 Million
% of Total Assets	-4.3%
Annual Growth Rate	N/A
5-Year Change	-102.37%
10-Year Change	-100.67%
Growth Volatility	3858.7

Hunan Jingfeng Pharmaceutical - Net Assets Trend (1995–2024)

This chart illustrates how Hunan Jingfeng Pharmaceutical's net assets have evolved over time, based on quarterly financial data. Also explore 000908 total asset value for the complete picture of this company's asset base.

Annual Net Assets for Hunan Jingfeng Pharmaceutical (1995–2024)

The table below shows the annual net assets of Hunan Jingfeng Pharmaceutical from 1995 to 2024. For live valuation and market cap data, see Hunan Jingfeng Pharmaceutical market cap and net worth.

Year	Net Assets	Change
2024-12-31	CN¥-15.13 Million ≈ $-2.21 Million	+90.16%
2023-12-31	CN¥-153.68 Million ≈ $-22.49 Million	-171.54%
2022-12-31	CN¥214.83 Million ≈ $31.44 Million	-34.45%
2021-12-31	CN¥327.73 Million ≈ $47.96 Million	-48.65%
2020-12-31	CN¥638.18 Million ≈ $93.39 Million	-67.13%
2019-12-31	CN¥1.94 Billion ≈ $284.15 Million	-32.15%
2018-12-31	CN¥2.86 Billion ≈ $418.81 Million	+10.08%
2017-12-31	CN¥2.60 Billion ≈ $380.45 Million	-0.48%
2016-12-31	CN¥2.61 Billion ≈ $382.27 Million	+16.19%
2015-12-31	CN¥2.25 Billion ≈ $329.02 Million	+126.19%
2014-12-31	CN¥994.04 Million ≈ $145.46 Million	+18624.95%
2013-12-31	CN¥5.31 Million ≈ $776.82K	+108.82%
2012-12-31	CN¥-60.15 Million ≈ $-8.80 Million	-7706.65%
2011-12-31	CN¥790.82K ≈ $115.72K	-98.63%
2010-12-31	CN¥57.85 Million ≈ $8.46 Million	-42.54%
2009-12-31	CN¥100.67 Million ≈ $14.73 Million	-70.27%
2008-12-31	CN¥338.64 Million ≈ $49.55 Million	+0.50%
2007-12-31	CN¥336.95 Million ≈ $49.31 Million	+0.17%
2006-12-31	CN¥336.40 Million ≈ $49.23 Million	+2.04%
2005-12-31	CN¥329.66 Million ≈ $48.24 Million	-2.88%
2004-12-31	CN¥339.45 Million ≈ $49.67 Million	-19.06%
2003-12-31	CN¥419.38 Million ≈ $61.37 Million	-19.77%
2002-12-31	CN¥522.69 Million ≈ $76.49 Million	+4.87%
2001-12-31	CN¥498.41 Million ≈ $72.93 Million	-0.43%
2000-12-31	CN¥500.54 Million ≈ $73.24 Million	+3.11%
1999-12-31	CN¥485.43 Million ≈ $71.03 Million	+21.17%
1998-12-31	CN¥400.62 Million ≈ $58.62 Million	+363.09%
1997-12-31	CN¥86.51 Million ≈ $12.66 Million	+42.21%
1996-12-31	CN¥60.83 Million ≈ $8.90 Million	+97.55%
1995-12-31	CN¥30.79 Million ≈ $4.51 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Hunan Jingfeng Pharmaceutical's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 104595230500.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Common Stock	CN¥416.69 Million	509.42%
Other Comprehensive Income	CN¥-305.87 Million	-373.95%
Other Components	CN¥1.02 Billion	1243.25%
Total Equity	CN¥81.80 Million	100.00%

Hunan Jingfeng Pharmaceutical Competitors by Market Cap

The table below lists competitors of Hunan Jingfeng Pharmaceutical ranked by their market capitalization.

Company	Market Cap
ASRock Inc TW:3515	$916.66 Million
China Resources and Environment Co Ltd SHG:600217	$916.90 Million
SKF India Limited NSE:SKFINDIA	$916.93 Million
Sun Create Electronics Co., Ltd SHG:600990	$917.10 Million
Intelbras S.A. - Indústria de Telecomunicação Eletrônica Brasileira SA:INTB3	$916.53 Million
Changzhou Tenglong Auto Parts SHG:603158	$916.36 Million
Guangxi Wuzhou Communications Co Ltd SHG:600368	$916.26 Million
Lelon Electronics Corp TW:2472	$916.05 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Hunan Jingfeng Pharmaceutical's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from -49,494,383 to 81,796,189, a change of 131,290,572.
Net income of 152,304,308 contributed positively to equity growth.
Dividend payments of 13,403,077 reduced retained earnings.
Other comprehensive income decreased equity by 57,367.
Other factors decreased equity by 7,553,292.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥152.30 Million	+186.2%
Dividends Paid	CN¥13.40 Million	-16.39%
Other Comprehensive Income	CN¥-57.37K	-0.07%
Other Changes	CN¥-7.55 Million	-9.23%
Total Change	CN¥-	%

Book Value vs Market Value Analysis

This analysis compares Hunan Jingfeng Pharmaceutical's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 76.59x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 90.59x to 76.59x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1995-12-31	CN¥0.08	CN¥7.12	x
1996-12-31	CN¥0.16	CN¥7.12	x
1997-12-31	CN¥0.22	CN¥7.12	x
1998-12-31	CN¥1.02	CN¥7.12	x
1999-12-31	CN¥1.16	CN¥7.12	x
2000-12-31	CN¥1.25	CN¥7.12	x
2001-12-31	CN¥1.27	CN¥7.12	x
2002-12-31	CN¥1.30	CN¥7.12	x
2003-12-31	CN¥1.02	CN¥7.12	x
2004-12-31	CN¥0.83	CN¥7.12	x
2005-12-31	CN¥0.84	CN¥7.12	x
2006-12-31	CN¥0.85	CN¥7.12	x
2007-12-31	CN¥1.07	CN¥7.12	x
2008-12-31	CN¥0.87	CN¥7.12	x
2009-12-31	CN¥0.17	CN¥7.12	x
2010-12-31	CN¥0.19	CN¥7.12	x
2011-12-31	CN¥0.00	CN¥7.12	x
2012-12-31	CN¥-0.20	CN¥7.12	x
2013-12-31	CN¥0.01	CN¥7.12	x
2014-12-31	CN¥1.95	CN¥7.12	x
2015-12-31	CN¥2.48	CN¥7.12	x
2016-12-31	CN¥2.72	CN¥7.12	x
2017-12-31	CN¥2.70	CN¥7.12	x
2018-12-31	CN¥2.82	CN¥7.12	x
2019-12-31	CN¥1.81	CN¥7.12	x
2020-12-31	CN¥0.59	CN¥7.12	x
2021-12-31	CN¥0.35	CN¥7.12	x
2022-12-31	CN¥0.20	CN¥7.12	x
2023-12-31	CN¥-0.06	CN¥7.12	x
2024-12-31	CN¥0.09	CN¥7.12	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Hunan Jingfeng Pharmaceutical utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 186.20%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 36.61%
• Asset Turnover: 0.44x
• Equity Multiplier: 11.49x
Recent ROE (186.20%) is above the historical average (-602.53%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1995	25.85%	11.80%	1.02x	2.15x	CN¥4.88 Million
1996	30.68%	27.21%	0.52x	2.16x	CN¥12.58 Million
1997	31.04%	40.76%	0.50x	1.53x	CN¥18.20 Million
1998	7.32%	33.97%	0.18x	1.18x	CN¥-10.72 Million
1999	12.50%	41.77%	0.20x	1.52x	CN¥11.37 Million
2000	9.42%	24.44%	0.27x	1.42x	CN¥-2.83 Million
2001	2.46%	7.15%	0.28x	1.25x	CN¥-37.50 Million
2002	2.74%	6.54%	0.25x	1.70x	CN¥-37.10 Million
2003	-13.17%	-24.30%	0.22x	2.45x	CN¥-92.83 Million
2004	-20.03%	-25.17%	0.29x	2.74x	CN¥-97.58 Million
2005	0.91%	1.39%	0.26x	2.56x	CN¥-29.84 Million
2006	0.81%	1.15%	0.29x	2.46x	CN¥-30.75 Million
2007	1.69%	3.01%	0.23x	2.44x	CN¥-27.73 Million
2008	-11.48%	-15.45%	0.22x	3.39x	CN¥-62.65 Million
2009	-444.36%	-100.88%	0.30x	14.63x	CN¥-243.81 Million
2010	5.22%	1.38%	0.46x	8.23x	CN¥-2.74 Million
2011	-17638.33%	-40.98%	0.33x	1304.81x	CN¥-57.00 Million
2012	0.00%	-41.85%	0.39x	0.00x	CN¥-54.75 Million
2013	68.17%	2.01%	0.50x	68.14x	CN¥2.87 Million
2014	25.58%	12.82%	1.02x	1.95x	CN¥152.91 Million
2015	14.91%	13.18%	0.71x	1.58x	CN¥106.74 Million
2016	14.21%	12.88%	0.51x	2.15x	CN¥100.81 Million
2017	6.81%	6.27%	0.53x	2.05x	CN¥-75.76 Million
2018	7.52%	7.22%	0.49x	2.10x	CN¥-61.55 Million
2019	-58.03%	-68.57%	0.31x	2.74x	CN¥-1.08 Billion
2020	-222.16%	-131.60%	0.33x	5.17x	CN¥-1.21 Billion
2021	-65.81%	-24.86%	0.45x	5.85x	CN¥-232.28 Million
2022	-56.70%	-12.00%	0.57x	8.25x	CN¥-118.68 Million
2023	0.00%	-32.75%	0.62x	0.00x	CN¥-210.19 Million
2024	186.20%	36.61%	0.44x	11.49x	CN¥144.12 Million

Industry Comparison

This section compares Hunan Jingfeng Pharmaceutical's net assets metrics with peer companies in the Drug Manufacturers - General industry.

Industry Context

Industry: Drug Manufacturers - General
Average net assets among peers: $1,672,566,033
Average return on equity (ROE) among peers: 1.90%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Hunan Jingfeng Pharmaceutical (000908)	CN¥-37.76 Million	25.85%	N/A	$916.62 Million
Zhejiang Int'L Group Co Ltd (000411)	$215.92 Million	3.15%	4.29x	$809.52 Million
Zhejiang Zhenyuan Share Co Ltd (000705)	$439.28 Million	4.77%	0.63x	$403.85 Million
Hubei Guangji Pharmaceutical Co Ltd (000952)	$481.54 Million	6.36%	0.40x	$374.97 Million
Yifan Xinfu Pharmaceutical Co Ltd (002019)	$703.64 Million	-28.08%	0.71x	$1.99 Billion
Guangdong Jiaying Pharmaceutical Co Ltd (002198)	$684.48 Million	0.22%	0.18x	$433.71 Million
Sichuan Kelun Pharmaceutical Co Ltd (002422)	$9.06 Billion	12.00%	0.65x	$8.08 Billion
Chongqing Lummy Pharmaceutical (300006)	$1.88 Billion	-4.66%	0.52x	$987.34 Million
Zhejiang Jolly Pharmaceutical Co Ltd (300181)	$1.49 Billion	3.03%	0.44x	$1.56 Billion
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357)	$90.44 Million	20.35%	0.22x	$1.95 Billion

About Hunan Jingfeng Pharmaceutical

SHE:000908 China Drug Manufacturers - General

Market Cap

$916.62 Million

CN¥6.26 Billion CNY

Market Cap Rank

#9485 Global

#2622 in China

Share Price

CN¥7.12

Change (1 day)

-3.39%

52-Week Range

CN¥4.58 - CN¥9.23

All Time High

CN¥16.99